protocolSection identificationModule nctId: NCT06355323, orgStudyIdInfo id: PT22020, briefTitle: Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France, acronym: PREDDICHA, statusModule overallStatus: RECRUITING, startDateStruct date: 2022-11-28, primaryCompletionDateStruct date: 2025-11-28, completionDateStruct date: 2025-11-28, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: CHU de Reims, class: OTHER, descriptionModule briefSummary: Primary humoral immunodeficiency (PHID), such as common variable immunodefiency, are the most common symptomatic primary immunodeficiency in adults, in France. Patients are more prone to infections (particularly bacterial upper and lower respiratory tract infections), auto-immunity and atopic manifestations. Morbidity and mortality in PHID are mainly linked to the presence of bronchiectasis, which can lead to infections and to chronic respiratory failure. However, bronchiectasis in these patients can be asymptomatic for a long time. There is no known predictive factors to identify patients more susceptible to develop bronchiectasis and notably, there was no link between the number of previous infectious episodes and bronchiectasis. A marked IgM deficiency and switched memory B cell deficiency might be associated with bronchiectasis.Thoracic CT-scan is recommended at PHID diagnosis but there is no guideline for follow-up, thus leading to bronchiectasis being under-diagnosis or leading to delayed diagnosis, conditionsModule conditions: Primary Immunodeficiency, conditions: Common Variable Immunodeficiency, conditions: Igg Subclass Deficiency, conditions: Selective IgM Deficiency, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: SCREENING, maskingInfo masking: NONE, enrollmentInfo count: 75, type: ESTIMATED, armsInterventionsModule interventions name: Blood test, interventions name: chest CT scan, outcomesModule primaryOutcomes measure: Thoracic CTscan, secondaryOutcomes measure: Pulmonary Function Test, secondaryOutcomes measure: Pulmonary Function Test, secondaryOutcomes measure: Pulmonary Function Test, secondaryOutcomes measure: Pulmonary Function Test, secondaryOutcomes measure: Pulmonary Function Test, secondaryOutcomes measure: Pulmonary Function Test, secondaryOutcomes measure: 6 minutes walking test, secondaryOutcomes measure: 6 minutes walking test, secondaryOutcomes measure: 6 minutes walking test, secondaryOutcomes measure: 6 minutes walking test, secondaryOutcomes measure: Quality of life questionnaires, secondaryOutcomes measure: Quality of life questionnaires, secondaryOutcomes measure: Immunophenotyping, secondaryOutcomes measure: Biochemical factors : desmosine seric concentration, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Damien JOLLY, status: RECRUITING, city: Reims, country: France, contacts name: Amélie SERVETTAZ, role: CONTACT, phone: 03 26 83 27 68 9, phoneExt: 0033, email: aservettaz@chu-reims.fr, contacts name: Ailsa ROBBINS, role: CONTACT, phone: 03 26 83 27 68, phoneExt: 0033, email: arobbins@chu-reims.fr, geoPoint lat: 49.25, lon: 4.03333, hasResults: False